TRIA
TMO icon

Trail Ridge Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Trail Ridge Investment Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.78M Sell
3,556
-171
-5% -$82.1K 0.75% 31
2026
Q1 		$1.83M Sell
3,727
-12
-0.3% -$6.51K 0.8% 32
2025
Q4 		$2.17M Buy
3,739
+6
+0.2% +$3.39K 0.93% 27
2025
Q3 		$1.81M Buy
3,733
+12
+0.3% +$5.59K 0.81% 31
2025
Q2 		$1.74M Sell
3,721
-145
-4% -$60.6K 0.84% 31
2025
Q1 		$1.92M Sell
3,866
-181
-4% -$98K 0.99% 26
2024
Q4 		$2.11M Sell
4,047
-101
-2% -$55.5K 1% 28
2024
Q3 		$2.39M Sell
4,148
-30
-0.7% -$17.8K 1.14% 24
2024
Q2 		$2.31M Sell
4,178
-16
-0.4% -$9.17K 1.19% 24
2024
Q1 		$2.44M Buy
4,194
+180
+4% +$101K 1.38% 21
2023
Q4 		$2.13M Sell
4,014
-38
-0.9% -$18.4K 1.31% 21
2023
Q3 		$2.05M Buy
4,052
+43
+1% +$22.9K 1.39% 19
2023
Q2 		$2.09M Sell
4,009
-53
-1% -$28.6K 1.29% 24
2023
Q1 		$2.34M Buy
4,062
+200
+5% +$113K 1.53% 14
2022
Q4 		$2.13M Hold
3,862
– – 1.46% 17
2022
Q3 		$2.08M Hold
3,862
– – 1.37% 16
2022
Q2 		$2.1M Sell
3,862
-30
-0.8% -$16.5K 1.42% 16
2022
Q1 		$2.3M Sell
3,892
-40
-1% -$23K 1.41% 13
2021
Q4 		$2.62M Buy
+3,932
New +$2.45M 1.58% 12

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Trail Ridge Investment Advisors's TMO Position: Q2 2026 in Review

Trail Ridge Investment Advisors reduced its Thermo Fisher Scientific (TMO) stake by 4.6% in Q2 2026, selling an estimated $82.1K and leaving 3,556 shares worth $1.78M. The position accounts for 0.75% of the portfolio, ranked #31.

Trail Ridge Investment Advisors first reported a position in TMO in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.62M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Trail Ridge Investment Advisors held 3,556 shares of Thermo Fisher Scientific worth $1.78M as of Q2 2026.
  • Trail Ridge Investment Advisors sold 171 Thermo Fisher Scientific shares in Q2 2026, an estimated $82.1K.
  • Thermo Fisher Scientific made up 0.75% of Trail Ridge Investment Advisors's portfolio in Q2 2026, its #31 holding.
  • Trail Ridge Investment Advisors first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 19 quarters since.
  • Trail Ridge Investment Advisors's Thermo Fisher Scientific position peaked at $2.62M in Q4 2021.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Trail Ridge Investment Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.